2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$78.60-$0.43 (-0.54%)
Price as of Aug 21, 2026 7:57 PM EDT- $3.3BMarket Cap
- 134.16%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$78.60-$0.43 (-0.54%)
KNSA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $79.03 | ||
Change | +$0.56 (+0.71%) | ||
Open | $78.28 | ||
High | $79.93 | ||
Low | $78.01 | ||
Previous Close | $78.47 | ||
Volume | 270,015 | ||
30-Day Average Volume | 665,971 | ||
1-Week Change | 2.97% | ||
1-Month Change | 24.36% | ||
1-Year Change | 134.16% | ||
3-Year Change | 359.21% | ||
5-Year Change | 547.79% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $896.1M | ||
Market Cap | $3.3B | ||
Enterprise Value | $3.1B | ||
Period: QTR TTM FY | |||
Revenue | $243.6M | ||
Net Income | $25.4M | ||
Free Cash Flow | $46.5M | ||
EBIT | $31.1M | ||
EBITDA | $31.6M | ||
Net Working Capital | $497.4M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | 99 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 5 | ||
P/E | 263 | ||
PEG | 24 | ||
Price/Free Cash Flow | 71 | ||
Price/Operating Cash Flow | 70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue